BELLEVUE GROUP AG Ultragenyx Pharmaceutical Inc. Transaction History

BELLEVUE GROUP AG portfolio value:

$0
portfolio value

BELLEVUE GROUP AG quarter portfolio value change:

-30.59%
quarter

Ultragenyx Pharmaceutical Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -100.00% -31K shares -1.84M $41.41 0
Q2 2022 share Increase +20.62% 5.3K shares -17K $59.66 31K
Q1 2022 share Increase +22.38% 4.7K shares 100K $72.62 25.7K
Q4 2021 share Decrease -24.73% -6.9K shares -750K $84.25 21K
Q3 2021 share Increase +30.37% 6.5K shares 476K $90.19 27.9K
Q2 2021 share Decrease -47.80% -19.6K shares -2.62M $95.35 21.4K
Q1 2021 share 0.00% 0 shares -1.00M $113.86 41K
Q4 2020 share 0.00% 0 shares 2.30M $138.43 41K
Q3 2020 share Increase +70.83% 17K shares 1.49M $82.19 41K
Q2 2020 share Increase +11.63% 2.5K shares 922K $78.22 24K
Q1 2020 share Increase 0.00% 21.5K shares 955K $44.43 21.5K
Q3 2019 share Decrease -100.00% -22.8K shares -1.44M $42.78 0
Q2 2019 share Decrease -23.49% -7K shares -619K $63.5 22.8K
Q1 2019 share Increase +34.23% 7.6K shares 1.10M $69.36 29.8K
Q4 2018 share Decrease -30.30% -9.65K shares -1.46M $43.48 22.2K
Q3 2018 share Decrease -18.65% -7.3K shares -578K $76.34 31.85K
Q2 2018 share Decrease -2.85% -1.15K shares 954K $76.87 39.15K
Q1 2018 share Decrease -1.47% -600 shares 158K $50.99 40.3K
Q4 2017 share Decrease -2.62% -1.1K shares -340K $46.38 40.9K
Q3 2017 share 0.00% 0 shares 622K $53.26 42K
Q2 2017 share 0.00% 0 shares -1.23M $62.11 42K
Q1 2017 share Decrease -2.33% -1K shares -176K $67.78 42K
Q4 2016 share 0.00% 0 shares -27K $70.31 43K
Q3 2016 share Increase +53.57% 15K shares 1.68M $70.94 43K
Q2 2016 share Increase +180.00% 18K shares 736K $48.91 28K
Q1 2016 share Increase 0.00% 10K shares 633K $63.31 10K